BEAMSTART Logo

HomeCompaniesProfile

Nirva

Evidence-based Traditional and Complementary Medicine brand 


Company Size

6 - 10 People

Year Founded

2021


About Nirva


Nirva is an evidence-based, traditional and complementary medicine (T&CM) brand offering treatment programs for chronic conditions in the US and the UK.
Our approach combines natural, holistic, side-effect-free methods, including personalized diets, one-on-one yoga, health coaching, and supplements designed by experts trained in traditional and modern medicine.

Latest Jobs


Financials Beta

Business Model: Not Specified

Revenues: Not Specified

Expenses: Not Specified

Debt: Request

Operating Status: Active

Funding Raised: $0

Investment Rounds: 0 Rounds

Funding Stage: Not Specified

Last Funding Date: Not Specified


Frequently Asked Questions

What industry is Nirva in?

Nirva is in the Healthcare and Medtech industry.

How long has Nirva been in business?

Nirva was established in 2021 (3 years in business).

Is Nirva currently hiring?

Yes, Nirva is currently hiring for 1 job positions.

Visit Nirva's Jobs Page to view a list of all open positions.

Which country is Nirva headquartered in?

Nirva is based in United Kingdom.

Share This Profile

More Companies

Craze Production

Events Management & Corporate Gifts

Wyndly

Life's better without allergies

Elpha

Professional network for women

Pasito

Personalized employee benefits communication and AI support

GAVEL

Live shopping marketplace

Questbook

SDK to learn about your users' identity, credentials and reputation

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.